Cover Story
By Matthew Bin Han Ong
The vast majority of patients with prostate cancer in the United States don't receive androgen deprivation therapy injections on time. Up to 84% of injections are delayed for patients on a 28-day schedule, according to an authoritative study published in the The Journal of Urology.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Rathmell steps down at NCI as Trump team considers candidates to replace her
Wafik El-Deiry, Harvey Risch have been interviewed - Trump 2016: A look back at the 45th president’s impact on oncology
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- As fire encroached, City of Hope prepared to evacuate its Duarte campus
- Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48